0
Signin
countryflagUS

18889881171

AAPL 190.415 0.3663% MSFT 422.65 -0.1016% GOOG 175.36 0.8512% GOOGL 174.14 0.9449% AMZN 185.71 -0.1505% NVDA 943.46 -0.3001% META 473.555 -1.6582% TSLA 174.87 0.5058% TSM 154.06 -0.977% LLY 776.1758 -1.3779% V 280.145 -0.2972% AVGO 1436.4972 0.0228% JPM 204.205 1.0366% UNH 522.225 0.9033% NVO 133.03 -1.2105% WMT 63.485 6.109% LVMUY 170.79 -0.2511% XOM 117.87 -0.5988% LVMHF 855.728 -0.1473% MA 461.6867 0.805%

Clarity Pharmaceuticals Ltd

Healthcare US CLRPF

2.68USD
-(-%)

Last update at 2024-05-16T16:50:00Z

Day Range

2.682.70
LowHigh

52 Week Range

0.481.19
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Income before tax -24.49925M -23.73695M - -
Minority interest - - - -
Net income -24.60245M -23.75458M - -
Selling general administrative 2.03M 9.07M - -
Selling and marketing expenses - - - -
Gross profit - - - -
Reconciled depreciation 0.10M 0.05M - -
Ebit -26.36351M -17.04749M -10.31330M -7.05729M
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -36.16406M -30.29097M - -
Other operating expenses - - - -
Interest expense - - - -
Tax provision 0.10M 0.02M - -
Interest income 1.86M 0.10M - -
Net interest income 1.86M 0.10M - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense 0.10M 0.02M - -
Total revenue - - - -
Total operating expenses - - - -
Cost of revenue - - - -
Total other income expense net 9.80M 6.46M - -
Discontinued operations - - - -
Net income from continuing ops -24.60245M -23.75458M - -
Net income applicable to common shares -24.60245M -23.75458M -10.22137M -6.95386M
Preferred stock and other adjustments - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 76.90M 99.82M - -
Intangible assets - - - -
Earning assets - - - -
Other current assets - - - -
Total liab 7.72M 7.59M - -
Total stockholder equity 69.18M 92.24M - -
Deferred long term liab - - - -
Other current liab 0.48M 0.49M 0.84M 0.41M
Common stock 132.82M 132.12M 44.90M 23.93M
Capital stock 132.82M 132.12M - -
Retained earnings -70.37427M -45.79569M -28.84960M -18.86558M
Other liab 0.18M 0.08M 0.08M 0.00915M
Good will - - - -
Other assets 0.01M 0.01M 0.01M 0.01M
Cash 31.21M 55.34M - -
Cash and equivalents - - - -
Total current liabilities 7.54M 7.51M 2.25M 0.95M
Current deferred revenue - - - -
Net debt - - - -
Short term debt - - - -
Short long term debt - - - -
Short long term debt total - - - -
Other stockholder equity 6.73M 5.92M 4.22M 3.09M
Property plant equipment 0.21M 0.26M 0.09M 0.05M
Total current assets 76.68M 99.55M 22.51M 9.05M
Long term investments 0.01M 0.01M - -
Net tangible assets 69.18M 92.24M 20.28M 8.16M
Short term investments 33.80M 37.00M - -
Net receivables 10.00M 6.66M 3.37M 2.66M
Long term debt - - - -
Inventory - - - -
Accounts payable 2.85M 2.85M 0.23M 0.16M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total 0.22M 0.27M - -
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Investments 3.20M -26.50036M -9.50000M -9.50000M
Change to liabilities 0.02M 4.93M 1.04M -0.28311M
Total cashflows from investing activities 3.15M -26.71351M -9.56031M -0.01450M
Net borrowings - - - -
Total cash from financing activities 0.23M 86.93M 20.41M 8.22M
Change to operating activities -0.92263M -0.01123M 0.13M 0.12M
Net income -24.60245M -23.75458M -10.22137M -6.95386M
Change in cash -24.12324M 46.90M 3.17M 1.37M
Begin period cash flow 55.34M 8.44M - -
End period cash flow 31.21M 55.34M 8.44M -
Total cash from operating activities -27.49996M -13.31392M -7.67708M -6.83030M
Issuance of capital stock 0.18M 92.40M - -
Depreciation 0.10M 0.05M 0.02M 0.02M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables -3.34464M -3.28566M -0.71229M -0.92392M
Sale purchase of stock -0.01275M -5.60315M - -
Other cashflows from financing activities -0.01275M -5.60315M -0.68122M 3.51M
Change to netincome 1.25M 8.77M 2.07M 1.19M
Capital expenditures 0.05M 0.21M 0.06M 0.01M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital - - - -
Stock based compensation - - - -
Other non cash items - - - -
Free cash flow -27.54652M -13.52707M - -

Fundamentals

  • Previous Close 2.68
  • Market Cap313.68M
  • Volume40000
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-26.26299M
  • Revenue TTM9.80M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 9.80M
  • Diluted EPS TTM-0.06

Peer Comparison

Sector: Healthcare Industry: Biotechnology

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
CLRPF
Clarity Pharmaceuticals Ltd		 - -% 2.68 - - 31.90 6.69 -7.0876
NVO
Novo Nordisk A/S		 -1.63 1.21% 133.03 41.58 31.15 2.13 32.99 2.11 4.70
NONOF
Novo Nordisk A/S		 0.57 0.43% 132.69 41.06 31.25 2.08 33.11 2.11 4.70
VRTX
Vertex Pharmaceuticals Inc		 1.20 0.27% 438.69 30.40 24.75 10.68 6.25 9.52 20.36
CSLLY
CSL Ltd		 1.03 1.09% 96.00 42.45 26.95 7.05 5.80 7.85 26.51

Reports Covered

Stock Research & News

View All

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).